Clinical Trial Update: Rituximab, Bendamustine and Cytarabine Followed by Venetoclax in High Risk Elderly Patients With MCL [Phase 2]

View source ↗

Summary

Phase 2 trial assessing rituximab, bendamustine, and cytarabine followed by venetoclax in high-risk elderly patients with mantle cell lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Bendamustine (Bendamustine)
• CYTARABINE (CYTARABINE)
• Rituximab (rituximab)
• Venetoclax (venetoclax)

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Lymphoma, Mantle-Cell | Phase 2 | Status: COMPLETED